Q32 Bio Inc (QTTB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access QTTB Annual Balance Sheets →
A period-by-period view of the balance sheet from Q32 Bio Inc to Jun 30 2025 helps clarify how Jun 30 2026's financial structure has changed over time.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent106.27
Cash & Short-term Investments106.00
Derivatives, Collateral, Regulatory, Deferred0.09
Other Current Assets1.88
Prepaid Expense And Other Assets Current0.76
Total Current Assets109.65
Equipment/Property/Plant Net2.82
Long-term investments0.65
Other Assets, Noncurrent2.75
Total Assets115.87
Liabilities
Accounts Payable, Current AC1.57
Accrued Liabilities, Current3.84
Line of Credit, Current LO0.00
Other Liabilities, Current0.00
Total Current Liabilities5.40
Long-term debt0.00
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent5.00
Other liabilities, Noncurrent0.00
Accrued Expenses And Other Liabilities Current3.78
Operating Lease Liability Noncurrent4.75
Total Liabilities9.96
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock327.45
Retained Earnings / Accumulated Deficit-221.55
Other Equity0.00
Common Stockholder's Equity105.91
Total Stockholder's Equity105.91
Liabilities & Stockholder's Equity115.87
4 historic quarters locked

Sign in to unlock the full Q32 Bio Inc balance sheet history.

About Q32 Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-333831

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.